ArticleThe Journal of biological chemistry2021

A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.

Xiao-Han Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.